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Introduction
Deep within the brain ticks a 24-hour clock that imparts 
circadian control over virtually every aspect of human 
physio  logy. This clock is located in the suprachiasmatic 
nucleus (SCN), which is a tiny region of the ventral hypo-
thalamus  that  contains  approximately  20,000  neurons 
[1,2]. The inherent timing capacity of the SCN is derived 
from  autonomous  neuronal  oscillators,  which  form  a 
coherent  and  precisely  phased  pattern  of  rhythmic 
neuronal activity and hormonal output that serves as a 
phasing cue to ancillary oscillators found throughout the 
brain and peripheral organs [3,4]. The need for a circa-
dian control center likely evolved as an adaptive response 
to the daily changes in the light-dark cycle resulting from 
the axial rotation of the earth. As such, the inherent clock 
timing process is tightly regulated by changes in the daily 
lighting cycle.
As discussed in detail below, dysregulation of the clock 
appears to play a central role in the genesis and progres-
sion  of  a  broad  range  of  disorders,  and  therapeutic 
approaches designed to target clock physiology (that is, 
chronotherapeutics)  have  been  effective  in  treating  a 
range of ailments, including seasonal affective disorder, 
asthma,  hypertension  and  cancer  [5-9].  Many  of  these 
treatment strategies are based on the integration of clock 
phase into the drug delivery schedule. However, if we are 
to develop novel chronotherapeutic approaches, then a 
deeper understanding of clock physiology (from cellular 
clock communication to mechanisms of molecular timing 
and organ-specific clock gene expression patterns) will be 
required. To this end, recent work by a number of groups 
has revealed a role for microRNAs in clock physiology. 
MicroRNAs  are  small  (approximately  22  nucleotides), 
single-stranded,  non-coding  RNA  species  that  act  as 
potent gene silencers and are important to a diverse array 
of physiological and pathophysiological processes [10-13]. 
As we will discuss in detail below, microRNAs appear to 
play distinct roles in clock physiology, and dysregulation 
of microRNA expression can lead to marked alterations 
in  circadian  timing  and  output.  Hence,  microRNAs 
present  novel  therapeutic  targets  for  disorders  of  the 
circadian clock. In this review, we will provide an over-
view  of  circadian  biology,  and  highlight  genome-scale 
and integrated approaches designed to reveal the role of 
microRNAs in clock physiology. Finally, we will provide 
some perspective on microRNAs as potential therapeutic 
targets for circadian disorders. By understanding the role 
of microRNAs in circadian biology on molecular, cellular 
and  organ-systems  levels,  a  cohesive  and  integrated 
approach to chronotherapeutics can be developed.
Abstract
The biochemical activity of a stunning diversity of 
cell types and organ systems is shaped by a 24-hour 
(circadian) clock. This rhythmic drive to a good deal 
of the transcriptome (up to 15% of all coding genes) 
imparts circadian modulation over a wide range 
of physiological and behavioral processes (from 
cell division to cognition). Further, dysregulation of 
the clock has been implicated in the pathogenesis 
of a large and diverse array of disorders, such as 
hypertension, cancer and depression. Indeed, the 
possibility of utilizing therapeutic approaches that 
target clock physiology (that is, chronotherapy) 
has gained broad interest. However, a deeper 
understanding of the underlying molecular 
mechanisms that modulate the clock, and give rise to 
organ-specific clock transcriptomes, will be required 
to fully realize the power of chronotherapies. Recently, 
microRNAs have emerged as significant players in 
circadian clock timing, thus raising the possibility 
that clock-controlled microRNAs could contribute 
to disorders of the human circadian timing system. 
Here, we highlight recent work revealing a key role for 
microRNAs in clock physiology, and discuss potential 
approaches to unlocking their utility as effectors of 
circadian physiology and pathophysiology.
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At a molecular level, the inherent 24-hour time-keeping 
capacity  of  the  SCN  stems  from  a  well-characterized 
transcriptional/post-translation  feedback  loop  (Figure 
1).  Central  to  this  molecular  clock  is  the  rhythmic 
expression  of  the  period  (per1  and  per2)  and 
cryptochrome  (cry1  and  cry2)  families  of  genes. 
Circadian transcription of per and cry genes is mediated 
by an E-box-binding basic helix-loop-helix transcription 
factor consisting of CLOCK (or NPAS2) and BMAL1. 
The  gene  products  of  per  and  cry  accumulate  in  the 
cytoplasm,  dimerize,  enter  the  nucleus,  and  repress 
transactivation of the CLOCK-BMAL1 complex [14,15].
If this negative feedback loop were the entire story, 
one would anticipate only a single robust round of per/
cry  gene  expression  would  occur,  and  then  a  steady, 
basal  level  of  gene  expression  would  persist.  Rather, 
rhythmic relief of per/cry repression is achieved in part 
via pro  gressive phosphorylation of PER by casein kinase 
1 delta and epsilon, which targets the proteins for poly-
ubiquity  lation and degradation via the 26S proteosomal 
pathway [16,17].
Here,  it  should  also  be  pointed  out  that  this  core 
molecular feedback loop is influenced by multiple clock-
influenced  feedback  regulators,  including  kinases  such 
as protein kinase A and the extracellular signal-related 
kinase (ERK)/mitogen-activated protein kinase (MAPK) 
cascade.  Likewise,  oscillations  in  transcriptional  path-
ways mediated by the nuclear hormone receptor Rev-
erb, the bZIP transcription factor E4BP4 [18] and the 
basic  helix-loop-helix  transcription  factors  Dec1  and 
Dec2 [19] modulate the amplitude and phasing of the 
clock  and  also  serve  as  output  pathways  that  impart 
circadian  control  over  an  array  of  biochemical  and 
physiological processes [20,21].
Entrainment  of  the  biological  clock  to  external  time 
cues appears to be mediated in part by rapid changes in 
the expression of per1 and per2. Along these lines, photic 
input drives a rapid increase in clock gene expression via 
an ERK/MAPK-cAMP response-element-binding protein 
(CREB)  signaling  cassette  in  the  SCN  [22]  (Figure  1). 
Conversely,  non-photic  entrainment  cues  have  been 
shown to trigger a rapid degradation of per1 and per2 
expression [23]. As state variables of the clock, changes in 
the expression of per1 and per2 would lead to resetting of 
the molecular oscillator, and in turn re-entrainment of 
the circadian rhythm.
A deeper understanding of the functional significance 
of  the  circadian  timing  process  was  realized  through 
gene-array-based analysis, which showed that large and 
diverse functional classes of genes within the SCN are 
under  the  control  of  the  core-clock  timing  processes 
[24,25]. Likewise, robust rhythmicity in the periphery has 
been  demonstrated  for  tissues,  including  the  liver  and 
heart [26-28]. A truly remarkable finding was the organ-
specific  nature  of  circadian  gene  expression  profile. 
Hence, beyond the canonical core clock genes, only small 
subsets of genes have been found to oscillate in multiple 
organ  systems;  along  these  lines,  Panda  et  al.  [25] 
reported that 28 genes (out of approximately 650) were 
found to oscillate in both the SCN and the liver. These 
findings reveal that clock-controlled gene expression is 
tailored to match the physiological role of the tissue.
Circadian modulation of disease
The  finding  that  circadian  timing  mechanisms  are 
distributed through the body raises important questions 
about the relevance of the clock to human health and 
disease.  Some  of  the  most  interesting  work  on  this 
subject has utilized animal models to assess the physio-
logical effects that disruption of timing has on disease 
progression. Along these lines, work by Filipski et al. [29] 
showed that destruction of the SCN accelerated malig-
nant tumor growth by up to threefold. Likewise, experi-
mental models that lead to a marked disruption of clock 
synchrony, such as constant light, and repetitive shifting 
of  the  light-dark  cycle,  have  been  shown  to  accelerate 
tumor  growth  and,  relatedly,  increase  mortality  rates 
[30-32]. In a telling parallel to these studies, a number of 
epidemiological studies have found that shift workers are 
at an elevated risk for several types of cancer, including 
breast,  colorectal  and  prostate  cancer  [33-35].  Given 
work  showing  that  the  circadian  clock  modulates  hor-
mone output, immune cell function and cell division, the 
postulation that disruption of the circadian clock occurs 
as  part  of  the  disease  progress  may  not  be  surprising. 
However, many of these studies have also hinted at the 
possibility that disruption of the clock may be a key factor 
in the initiation of a disease state. In this regard, work in 
mouse models in which components of the core clock 
timing process are disrupted via genetic-based approaches 
have  been  particularly  enlightening.  Along  these  lines, 
Clock mutant mice are obese and hyperphagic, exhibiting 
hyperleptinemia,  hepatic  steatosis  hyperglycemia  and 
hypoinsulinemia [36]. In an interest  ing affirmation of the 
connection between the clock and metabolic disorders, 
SNP analysis of lean and obese humans has revealed an 
association between CLOCK polymorphisms and suscep-
tibility to obesity [37]. In addition, haplotype analysis has 
identified CLOCK gene variants that may be protective 
against the development of obesity or that contribute to 
the development of metabolic syndrome, type 2 diabetes 
and cardiovascular disease [38]. It also appears that key 
components  of  the  molecular  clock  are  affected  by 
alterations in metabolic activity. Along these lines, mice 
maintained on a high-fat diet, thus leading to obesity and 
metabolic syndromes, exhibited a marked alteration in 
core Clock gene expression within the liver and kidneys 
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and  lifestyle  factors  that  impact  metabolic  fitness  via 
alterations in circadian clock function.
Disruption  of  clock  timing  has  also  been  shown  to 
contribute to an array of nervous system disorders. Along 
these  lines,  familial  advanced  sleep  phase  syndrome 
(FASPS) is an autosomal dominant disorder characterized 
by a 3- to 4-hour advance in sleep onset and awakening 
[40]. Hence, an individual with FASPS may fall asleep at 
7 pm rather than 11 pm, and with arousal at 3 am instead 
of  7  am.  Linkage  analysis  revealed  that  FASPS  was 
localized to a point mutation in the PER2 gene [41]. At a 
mechanistic level, this mutation is thought to eliminate a 
phosphorylation motif for casein kinase 1 epsilon, thus 
leading to excessive accumulations of PER2 and, in turn, 
an altered/advanced circadian cycle, initiating premature 
drive for sleep onset. Interestingly, dysregulation of the 
clock also appears to contribute to disturbances of the 
sleep-wake cycles in individuals with Alzheimer’s disease. 
These  spontaneous  night-time  awakenings  in  patients 
with Alzheimer’s disease are one of the most challenging 
issues for caregivers [42]. Likewise, individuals suffering 
from Huntington’s disease exhibit clock-regulated dis  rup-
tion  of  neuroendocrine  output,  and  of  the  sleep-wake 
cycles [43-45]. These examples are a mere shortlist of the 
profound functional roles that the clock plays in organ-
ismal physiology. The role of the clock in such diverse 
processes as cell division and xenobiotic responses, and 
its roles in regulation of behavior, cognition, arousal and 
aging are reviewed elsewhere [46-48].
Molecular control through microRNA
To  further  our  understanding  of  the  molecular  under-
pinnings of the circadian clock, researchers have begun 
to explore the potential role of the non-coding class of 
small RNA species known as microRNAs. MicroRNAs 
are potent negative regulators of mRNA translation and, 
as such, play a central role in sculpting gene expression 
patterns.  MicroRNAs  are  principally  coded  within 
introns and exons of non-coding RNA (that is, intergenic 
microRNA), and from introns of protein encoding genes 
(that is, introgenic microRNA) [49,50]. MicroRNAs are 
Figure 1. Schematic overview of molecular circadian clock 
timing. (a) Suprachiasmatic nucleus (SCN; red circles) located 
within the ventral hypothalamus. The two nuclei serve as the master 
circadian clocks, orchestrating rhythmicity and phasing of ancillary 
clocks found in peripheral organ systems (c1) and throughout the 
brain (c2). Entrainment of the SCN clock to light is mediated by a 
direct projection from the retina. (b) The molecular clock feedback 
loop is centered on the rhythmic expression of the period (per1/2) 
and cryptochrome (cry1/2) gene families. PERIOD and CRY dimers 
translocate to the nucleus and negatively regulate their own 
production via suppression of CLOCK (CLK)- and BMAL1-mediated 
transcription. Casein kinase 1 (CK1)-mediated phosphorylation 
triggers degradation of PER proteins, thus relieving transcriptional 
repression and, in turn, allowing for robust 24-hour clock gene 
cycling. In addition to the core clock genes, a large fraction of 
the transcriptome is under the direct or indirect influence of the 
circadian clock. The clock-controlled transcriptome (CCT) within 
the SCN includes hormones, kinases, transcription factors and 
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microRNAs. Many of these gene products serve as phasing cues to 
ancillary oscillators, or function as feedback regulators of the core 
molecular clock. (c1) Clock-regulated microRNA expression in the 
liver: denotation of several rhythmically expressed microRNAs that 
are either predicted (that is, miR181d and miR191 [69]) or have 
been shown (that is, miR192/194 [71]) to target components of 
the core molecular clock. MiR122 has been shown to modulate 
clock-controlled gene expression involved in hepatic cholesterol 
and lipid metabolism [72,74]. In total, these data strongly indicate 
that microRNAs play a central role in sculpting the circadian gene 
expression profile and, in turn, regulate associated physiological and 
behavioral processes.
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cribed as long RNA that contains multiple microRNAs in 
a  cluster  (polycistronic  microRNAs)  [50,51].  The  bio-
genesis  of  microRNAs  occurs  via  a  multistep  process, 
which is described in detail elsewhere [52-54]. In short, 
microRNAs  are  transcribed  by  RNA  polymerase  II  as 
long single-stranded RNA, forming stem-loop (hairpin) 
structures, referred to as primary microRNAs. Primary 
microRNAs are processed to precursor microRNAs (55 
to 70 nucleotides) by a protein complex of RNAase III 
enzyme Drosha and the double-stranded RNA-binding 
domain  protein  DGCR8/Pasha  in  the  nucleus  [55-57]. 
Precursor  microRNAs  are  then  exported  to  the  cyto-
plasm where they are further processed to approximately 
22  bp  microRNA/microRNA*  double-stranded  species 
by a protein complex of RNAase III enzyme, Dicer, and 
double-stranded  RNA-binding  domain  proteins  TRBP/
PACT/loquacious [58,59]. Finally, microRNAs are loaded 
into the RNA-induced silencing complex, through which 
the gene silencing function of microRNAs occurs via a 
reduction  in  mRNA  translation  efficiency  or  mRNA 
stability [60-62].
MicroRNA and clock timing
Rhythmic control of microRNA expression appears to be 
conserved from plants to mammals, and has significant 
consequences  for  circadian  timing.  Along  these  lines, 
genome-wide tiling arrays have been used to profile the 
transcriptome of Arabidopsis thaliana as a function of 
the circadian cycle. Beyond the observation that approxi-
mately  25%  of  the  coding  genes  exhibited  circadian 
rhythms  of  expression,  several  rhythmically  regulated 
micro  RNAs (that is, miR160B and miR167D) were identi-
fied  [63].  This  experiment  was  not  designed  to  detect 
microRNA, and thus it is likely that the results under-
estimate the total number of oscillating microRNAs.
In  addition  to  circadian  control  mechanisms,  bio-
logically relevant time cues, such as the daily light cycle, 
also drive rhythmic microRNA expression. Along these 
lines, Arabidopsis miR167, miR168, miR171 and miR398 
have recently been shown to oscillate, with higher levels 
during the daytime than during the night [64] (Table 1). 
Interestingly, rhythmicity of these microRNAs was not 
governed  by  an  internal  circadian  clock,  suggesting 
photic control of some microRNAs. Within humans, it 
would not be surprising to observe a similar pattern of 
microRNA  expression  driven  by  the  clock,  exogenous 
time cues or both.
Circadian-regulated  microRNA  expression  has  also 
been described in Drosophila melanogaster. Array analy-
sis of wild-type flies revealed that miR263a and miR263b 
showed robust circadian oscillations, which were absent 
in  clock  mutant  flies  [65]  (Table  1).  In  a  later  study, 
Kadener et al. [66] found that abrogation of microRNA 
biogenesis  led  to  both  a  marked  rise  in  circadian-
regulated gene expression and a disruption of circadian-
regulated behavioral rhythms, thus indicating a role for 
microRNA  in  clock  timing.  AGO1  pull-down  assays 
revealed  that  gene  products  involved  in  clock  timing 
were targeted for microRNA-mediated degradation [64], 
indicating that core clock molecular feedback is not only 
regulated at a transcriptional and post-translational level, 
but  also  through  post-transcriptional/microRNA-medi-
ated control mechanisms.
In  the  mammalian  SCN,  microRNAs  play  a  role  in 
clock timing and entrainment. Cheng et al. [12] demon-
strated that both miR132 and miR219 show oscillatory 
expression in wild-type mice, but not in circadian mutant 
mice.  Both  microRNAs  have  CRE-enhancer  sequences 
allowing for CREB-dependent regulation [67], but only 
miR132 was shown to be inducible by light [12]. Impor-
tantly, miR219 appears to be under direct control of the 
molecular clock via the binding of CLOCK and BMAL1 
to  an  E-box  within  its  promoter  region.  In  contrast, 
miR132 does not contain an E-box motif, and thus its 
rhythmicity  is  likely  driven  by  an  ancillary  CREB-
actuated transcriptional oscillator [12]. In vivo antisense 
silencing studies demonstrated that miR219 shortens the 
circadian  period  and  that  miR132  negatively  regulates 
light-dependent resetting of the clock [12]. Both miR132 
and  miR219  affect  per1  expression,  and  thus  influence 
the core circadian transcriptional loop [12,68]. However, 
neither  miR132  nor  miR219  appears  to  directly  target 
per1;  thus,  the  precise  mechanisms  by  which  these 
microRNAs affect the clock are not known.
MicroRNA and peripheral circadian oscillators
In  addition  to  rhythmic  microRNA  expression  in  the 
SCN  clock,  peripheral  oscillators  also  exert  circadian 
control over microRNA expression. A microarray-based 
study of mouse liver revealed that over 13% of the probed 
microRNAs (85 out of 640) exhibited circadian expres-
sion  patterns  [69].  Target  prediction  analysis  indicated 
that  a  number  of  cycling  microRNAs  were  capable  of 
binding to components of the core clock timing process 
and,  for  a  subset  of  these  microRNAs,  there  was  an 
inverse  expression  pattern  with  their  predicted  clock 
gene targets. For example, expression of miR181d and its 
putative  target  CLOCK,  and  miR191  and  its  putative 
target BMAL1, were inversely correlated [69]. Conversely, 
miR328 and miR383 were positively correlated with the 
expression of their corresponding targets, per1 and cry. 
This  unexpected  relationship  may  be  the  result  of  a 
phase-lag  in  downregulation,  or  it  may  represent  an 
example of positive microRNA regulation that has been 
uncovered in recent years [70].
In another study, a forward genetic screen was used to 
identify the miR192/194 gene cluster as inhibitors of the 
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miR192/194 cluster is highly expressed in the liver and 
kidneys (two oscillating organs) [72] and overexpression 
studies found that miR192/194 shortens the length of the 
circadian rhythm via a decrease in per gene expression.
The expression of miR122, a known regulator of liver 
metabolism  [73],  is  also  subject  to  circadian  control. 
Although the mature strand microRNA does not osci  l-
late, both primary and precursor miR122 show robust 
daily  changes  in  expression,  suggesting  that 
transcription  is  under  circadian  control  [74]. 
Knockdown of miR122 revealed a marked alteration in 
the expression of clock-controlled genes, many of which 
are involved in chol  esterol and lipid metabolism. In an 
additional  study,  Kojima  et  al.  [75]  found  that  the 
rhythmic  expression  of  the  mRNA  deadenylase 
Nocturnin  is  modulated  by  miR122  in  the  liver, 
suggesting  that  miR122  is  a  key  intermediate  in 
circadian regulation of hepatic metabolic activity.
Intestine physiology is also governed by the circadian 
oscillator, which synchronizes enterocyte proliferation 
and, in turn, nutrient absorbance. Within this context, it 
is  interesting  that  miR16,  miR20a  and  miR141  all 
oscillate in the intestine, and that miR16 regulates the 
rate  of  proliferation  in  jejunal  crypts  by  suppressing 
essential  G1/S  cell  cycle  regulators  [76].  Hence, 
microRNA may serve as a link in the circadian control 
of intestinal physiology.
Finally, several microRNAs have been found to exhibit 
diurnal oscillations in the mouse retina, including miR96, 
miR124a,  miR103,  miR182,  miR106b,  miR422a  and 
miR422b [77]. Of these, both miR96 and miR182 show 
potential  targeting  and  downregulation  of  the  clock-
regulated  gene  adenylyl  cyclase  6.  In  a  separate  study, 
miR26a, which is regulated by both CLOCK and CREB, 
was found to drive circadian rhythms in the production 
of the L-type voltage-gated calcium channel α1C subunit 
in cone photoreceptors [78]. This observation is of func-
tional  significance,  given  the  central  role  that  L-type 
calcium channels play in rhythmic melatonin synthesis 
and, in turn, circadian retinal physiology [79,80]. Finally, 
in humans, a polymorphism in pre-miR182 (which exhi-
bits diurnal rhythmicity in the retina [77]) is significantly 
associated with major depression [81]. Relative to wild-
type  miR182,  mutant  miR182  was  found  to  trigger  a 
marked reduction in the expression of the circadian gene 
Clock. These data raise the possibility that mutant miR182 
contributes to circadian clock ailments associated with 
major depression [82].
Chronotherapeutic approaches and future outlook
The  finding  that  microRNA  affects  key  clock  timing 
processes  (that  is,  the  core  molecular  oscillator,  clock 
entrain  ment and clock output) raises the prospect that 
chronotherapeutic approaches designed to affect micro-
RNA physiology might prove efficacious.
Along these lines, some of the most tractable ailments 
associated  with  clock  physiology  may  result  from  a 
damped SCN oscillator, which is observed as part of the 
aging process [83-85]. Hence, approaches to increase the 
robustness of the clock timing process may offset frag  men-
tation of the sleep-wake cycle, which is often ob  served as a 
function  of  aging.  This  approach  could  also  prove 
beneficial  to  individuals  suffering  from  age-regulated 
neurodegenerative disorders, such as Alz  heimer’s disease. 
Therapeutic approaches could take the form of microRNA 
antisense or ‘sponge’ constructs [86], designed to target 
particular microRNAs, and in turn limit their ability to 
suppress components of the core clock timing process, or 
clock output genes. Of note, in mouse models, microRNA 
knockdown  using  cholesterol-conjugated  2-O-methyl 
RNA antisense (that is, antago  mirs [87]) has already been 
used to assess the functional roles of miR132 and miR219 
in SCN clock physiology [12]. Conversely, transgenic RNA 
interference-based  approaches  designed  to  harness  the 
endogenous  micro  RNA  processing  machinery  could  be 
used to selectively uncouple an aberrant clock-timing gene 
or clock-output gene from a specific physiological process. 
This approach could prove particularly useful as part of a 
cancer treatment strategy.
Table 1. Light and clock-controlled microRNAs
Model  Organ  MicroRNAs  Reference(s) 
Cell culture    miR328, miR383  [70]
Arabidopsis    miR160, miR167, miR168, miR171, miR398  [63,64]
Drosophila    miR263  [65]
Chicken  Photoreceptors  miR26a  [78]
Rat  Intestine  miR16, miR20a, miR141  [76]
Mouse  Liver  miR122, miR181, miR191  [69,73-75]
  Retina  miR96, miR103, miR106, miR124, miR182, miR422  [77]
  Suprachiasmatic nucleus  miR219, miR132  [12]
Human    miR182  [81]
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need to be addressed for these types of approaches to be 
implemented.  For  example,  the  inability  of  RNA  con-
structs (for example, antagomirs and sponges) to cross 
the  blood-brain  barrier  is  a  significant  impediment  to 
minimally invasive therapeutic strategies. Further, issues 
related  to  the  timing  of  antisense  administration  and 
organ-specific  therapeutic  targeting  will  need  to  be 
addressed. At the least, the practical application of these 
methods will require a deeper understanding of micro-
RNA biology, the clock, and its role in the regulation of a 
myriad  of  gene  networks  that  contribute  to  human 
physiology and pathology.
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